Story thread · 2 reports / 2 sources
QurCan Therapeutics Enters Strategic Research and Collaboration Agreement with Lilly to Advance Nucleic Acid Therapies for Central and Peripheral Nervous System Diseases
en.antaranews.com · 3h
-QurCan Therapeutics (“QurCan”), a biotechnology company pioneering non-viral, polymer-lipid nanoparticle ...
First report: QurCan Therapeutics Enters Strategic Research and Collaboration Agreement with Lilly to Advance Nucleic Acid Therapies for Central and Peripheral Nervous System Diseases — financialpost.com, 1d
The conversation · 0
Sign in to join the conversation.
No comments yet — start the thread.